Search Results

Pediatric Colorectal Research Fellowship

The Pediatric Colorectal Research Fellowship is a one or two-year program. The fellow will research the treatment and long-term outcomes of patients with pediatric colorectal problems and may also possess surgical assistant responsibilities.

Pediatric Colorectal Fellowship

The Pediatric Colorectal Fellowship is a one-year program, or a two-year program with additional research that provides training in advanced colorectal surgery and collaborating specialties, including GI motility and pelvic reconstruction.

Article

Breuer Lab

The focus of the Breuer and Shinoka Labs is to design a tissue engineered vascular graft (TEVG) that can be used during surgery that, over time transitions to a normal blood vessel that will grow with our pediatric patients.

Article

Shinoka Lab

Under the direction of Toshiharu Shinoka, MD, PhD, the Shinoka Lab works closely with Dr. Christopher Breuer's lab in optimizing Tissue Engineered Vascular Grafts (TEVGs) in animal models, with the goal of translating the work to humans.

Article

Lab Staff

Learn more about Toshiharu Shinoka, MD, PhD, and his dynamic team in the Shinoka Lab.

Core Facilities

On-site basic, clinical and general core services offer the latest resources for cutting-edge research support at the Abigail Wexner Research Institute at Nationwide Children's Hospital.

Resources & Infrastructure

The Abigail Wexner Research Institute at Nationwide Children's Hospital has a wealth of resources available to our researchers to ensure they have the tools they need to continue our mission of enhancing the health of children by engaging in high quality, cutting-edge research according to the

Article

CRISPR / Gene Editing Core

The team of experts available through the CRISPR/Gene Editing Core at Nationwide Children’s, in collaboration with The Ohio State University, provides investigators at both institutions with CRISPR/Gene Editing services with reasonable turnaround times and at affordable prices.

Article

Kararoudi Lab

Under the direction of Meisam Naeimi Kararoudi, DVM, PhD, the Kararoudi Lab aims to develop novel cancer immunotherapies through CRISPR-Cas9 genome editing and screening technology.